Home

Additivo assistenza conferenza eudralex vol 10 clinical trials liberale mar Mediterraneo beneficenza

New Cro Audit Form | PDF | Clinical Trial | Audit
New Cro Audit Form | PDF | Clinical Trial | Audit

page 1 of 3 Version 1.0, 26 March 2020 Supplementary recommendations to the  document European Guidance on the Management of Cl
page 1 of 3 Version 1.0, 26 March 2020 Supplementary recommendations to the document European Guidance on the Management of Cl

The CTR: what, when, why and how?
The CTR: what, when, why and how?

Frontiers | Advanced Therapy Medicinal Products' Translation in Europe: A  Developers' Perspective
Frontiers | Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective

Commission Guideline — Guidance on posting and publication of  result-related information on clinical trials in relation to the
Commission Guideline — Guidance on posting and publication of result-related information on clinical trials in relation to the

Update on the Clinical Trials Regulation (EU) No 536/2014 - Key developments
Update on the Clinical Trials Regulation (EU) No 536/2014 - Key developments

AIFA notice (update of the AIFA notice published on 12 March 2020) Clinical  trials' management in Italy during the COVID-19 (
AIFA notice (update of the AIFA notice published on 12 March 2020) Clinical trials' management in Italy during the COVID-19 (

New documents in EudraLex Volume 10 Clinical trials guidelines including an  updated CTA form
New documents in EudraLex Volume 10 Clinical trials guidelines including an updated CTA form

PPT - REVISION OF EUDRALEX VOL. 4 - GMP Luisa Stoppa, Ph.D. Inspection and  Certification Department PowerPoint Presentation - ID:6720277
PPT - REVISION OF EUDRALEX VOL. 4 - GMP Luisa Stoppa, Ph.D. Inspection and Certification Department PowerPoint Presentation - ID:6720277

DIRECTIVE” 2001/20/EC
DIRECTIVE” 2001/20/EC

Updated Draft Q&As for Clinical Trials Regulation 536/2014 released in EudraLex  Volume 10
Updated Draft Q&As for Clinical Trials Regulation 536/2014 released in EudraLex Volume 10

The Tao of Excellence on Twitter: "... good manufacturing practices (#GMPs)  in the #clinicaltrial application, describes the content of the protocol  synopsis,...3/5 #regulatoryaffairs #clinicalinvestigations #MDR #EU #Europe  #clinicaltrials ...
The Tao of Excellence on Twitter: "... good manufacturing practices (#GMPs) in the #clinicaltrial application, describes the content of the protocol synopsis,...3/5 #regulatoryaffairs #clinicalinvestigations #MDR #EU #Europe #clinicaltrials ...

PDF) Untangling the web of European regulations for the preparation of  unlicensed radiopharmaceuticals | Clemens Decristoforo - Academia.edu
PDF) Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals | Clemens Decristoforo - Academia.edu

The Parallel Universes of Eudralex Vol 10 – JoBurmester.com
The Parallel Universes of Eudralex Vol 10 – JoBurmester.com

Scan to personal folder
Scan to personal folder

Clinical Trials Toolkit Trial Supplies - PDF Free Download
Clinical Trials Toolkit Trial Supplies - PDF Free Download

The use of EudraLex Volume 10 and the coming EU Clinical Trials Regulation  536/2014
The use of EudraLex Volume 10 and the coming EU Clinical Trials Regulation 536/2014

EudraLex - Volume 10 - Clinical trials guidelines UPDATED
EudraLex - Volume 10 - Clinical trials guidelines UPDATED

PDF) Clinical trial disclosure and transparency: Regulation EU No. 536/2014  Public disclosure at the clinical trial level
PDF) Clinical trial disclosure and transparency: Regulation EU No. 536/2014 Public disclosure at the clinical trial level

European Regulatory Framework and General Path to Market for ATMPs
European Regulatory Framework and General Path to Market for ATMPs

Clinical Trials Regulation (CTR) for medicinal products in application on  31 January 2022
Clinical Trials Regulation (CTR) for medicinal products in application on 31 January 2022

GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP  INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT
GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT

EudraLex - Volume 10 Clinical trials guidelines
EudraLex - Volume 10 Clinical trials guidelines

Pharmaceuticals | Free Full-Text | Quality Assessment of Investigational  Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical  Trials Office | HTML
Pharmaceuticals | Free Full-Text | Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office | HTML

Guidance for the Submission and Conduct of Clinical Trials (CT) with  Medicinal Products - PDF Free Download
Guidance for the Submission and Conduct of Clinical Trials (CT) with Medicinal Products - PDF Free Download